The JAK2V617 mutation induces constitutive activation and agonist hypersensitivity in basophils from patients with polycythemia vera
Lisa Pieri, Alessandro M. Vannucchi(University of Florence)
Cited by 64
Related Papers
Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis
|Blood|2014|722
Co‐targeting the PI3K/ <scp>mTOR</scp> and JAK2 signalling pathways produces synergistic activity against myeloproliferative neoplasms
|Journal of Cellular and Molecular Medicine|2013|136